优化青春前期女孩卵巢组织冷冻保存前促性腺激素预处理后的卵母细胞体外成熟结局
这项回顾性队列研究纳入167例3-18岁青春前期女孩,在卵巢组织冷冻保存前给予3天外源性促性腺激素(Gn)预处理,发现Gn组体外成熟(IVM)卵母细胞成熟率高于对照组(49.2% vs 36.2%),3-5岁组获益最大(OR=3.04,95%CI 1.21-7.65),而12-18岁组改善不显著(OR=2.04,95%CI 0.78-5.36)。
要点
- Gn预处理3天可使青春前期女孩IVM卵母细胞成熟率由36.2%提高至49.2%。
- 3-5岁组获益最大(OR=3.04,95%CI 1.21-7.65),6-11岁组中等(OR=1.67,95%CI 1.03-2.69)。
- 150 IU与225 IU Gn剂量间成熟率无显著差异(47.3% vs 51.1%,OR=0.99,95%CI 0.69-1.43)。
核心结论
- Gn预处理可提高青春前期女孩卵巢组织冷冻保存中IVM的卵母细胞成熟率,年龄越小获益越明显,尤其6岁以下。
- 作者认为Gn预处理可作为优化青春前期女孩生育力保存方案的辅助手段,但需进一步研究以阐明分子机制并完善Gn刺激策略。
研究设计与样本
- 回顾性队列研究,在大学附属三级医疗中心开展。
- 纳入167例3-18岁青春前期女孩,计划于2021年7月至2024年9月间接受造血干细胞移植,既往均未暴露于化疗。
- 暴露为卵巢组织冷冻保存前给予3天外源性Gn。
- 主要结局指标为IVM卵母细胞成熟率。
主要发现
- Gn组与对照组获卵数相当(中位数[四分位距]:9.5[6.0-14.0] vs 8.0[6.0-11.0])。
- Gn组IVM成熟率高于对照组(49.2% vs 36.2%)。
- 3-5岁组获益最大(OR=3.04,95%CI 1.21-7.65),6-11岁组中等(OR=1.67,95%CI 1.03-2.69),12-18岁组改善不显著(OR=2.04,95%CI 0.78-5.36)。
- Gn 150 IU与225 IU组IVM成熟率无显著差异(47.3% vs 51.1%,OR=0.99,95%CI 0.69-1.43)。
- 颗粒细胞转录组分析提示Gn预处理可能通过调节线粒体功能、类固醇生成、DNA修复和纺锤体组装相关通路增强卵母细胞成熟。
关键数值与推荐
- Gn组IVM成熟率49.2%,对照组36.2%。
- 3-5岁组OR=3.04(95%CI 1.21-7.65);6-11岁组OR=1.67(95%CI 1.03-2.69);12-18岁组OR=2.04(95%CI 0.78-5.36)。
- Gn 150 IU组成熟率47.3%,225 IU组51.1%,OR=0.99(95%CI 0.69-1.43)。
临床怎么用
- 作者认为Gn预处理可作为优化青春前期女孩生育力保存方案的辅助手段,尤其6岁以下儿童。
- 作者建议需进一步研究以阐明分子机制并完善该人群的Gn刺激策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of gonadotropin (Gn) priming on oocyte maturation outcomes during in vitro maturation (IVM) in premenarcheal girls undergoing ovarian tissue cryopreservation for fertility preservation. DESIGN: A retrospective cohort study conducted at a university-affiliated tertiary care medical center. SUBJECTS: A total of 167 premenarcheal girls aged 3-18 years scheduled for hematopoietic stem cell transplantation between July 2021 and September 2024. None of the patients had been exposed previously to chemotherapy. EXPOSURE: Administration of exogenous Gn for 3 days prior to ovarian tissue cryopreservation. MAIN OUTCOME MEASURES: Oocyte maturation rate of IVM. RESULTS: Ovarian tissue from premenarcheal girls expressed Gn receptors and responded to exogenous Gn stimulation. Although the number of retrieved oocytes was comparable between the Gn and control groups (median [interquartile range]: 9.5 [6.0-14.0] vs. 8.0 [6.0-11.0]), higher maturation rates were observed in the Gn group than in the control group (49.2% vs. 36.2%). Subgroup analysis revealed the greatest benefit in the youngest age group (3-5 years; odds ratio [OR] = 3.04, 95% confidence interval [CI]: 1.21-7.65), whereas a moderate effect was observed in children aged 6-11 years (OR = 1.67, 95% CI: 1.03-2.69). In adolescents aged 12-18 years, the improvements were less pronounced and were not significant (OR = 2.04, 95% CI: 0.78-5.36). No significant difference in maturation rates of IVM was observed between Gn doses of 150 IU (47.3%) and 225 IU (51.1%) (OR = 0.99, 95% CI: 0.69-1.43). Transcriptomic analysis of granulosa cells suggested that Gn priming may enhance oocyte maturation by modulating pathways related to mitochondrial function, steroidogenesis, deoxyribonucleic acid repair, and spindle assembly. CONCLUSION: Gn priming improves oocyte maturation rates of IVM in premenarcheal girls undergoing fertility preservation, with the most pronounced benefit observed in younger children. These findings highlight the potential of Gn priming as an adjunct to optimize fertility preservation protocols in premenarcheal girls, particularly in those under 6 years of age. Further studies are warranted to elucidate the molecular mechanisms underlying these effects and to refine Gn-based stimulation strategies for this unique population.
引用
- Zhao W, Guo Y, Zhou C, et al. Optimizing in vitro maturation outcomes of oocytes following gonadotropin priming in premenarcheal girls undergoing ovarian tissue cryopreservation. Fertil Steril. 2025. PMID: 40588149. doi:10.1016/j.fertnstert.2025.06.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。